Thus, further research on platelet functions may give rise to numerous new antiplatelet agents with high anti-thrombotic efficiency and low adverse hemorrhagic side effects. †There are ...

Finally, a recent study suggested that although prasugrel significantly reduces thrombotic events in patients with ACS undergoing PCI because of its superior antiplatelet potency compared with ...

Initial medical management of STEMI consists of relief of ischemic pain with nitrates and morphine, antithrombotic measures including antiplatelet agents (aspirin, thienopyridines and glycoprotein ...